Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-05-02 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion +30,000 $10.69 $321K 129,739
2018-05-02 Labrucherie Gil M SVP & Chief Financial Officer Sale −30,000 $85.63 $2.6M 99,739
2018-05-02 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion · Stock Option −30,000 30,000
2018-05-02 ROBIN HOWARD W President & CEO Exercise or conversion +43,333 $10.69 $463K 280,480
2018-05-02 ROBIN HOWARD W President & CEO Sale −43,333 $85.63 $3.7M 237,147
2018-05-02 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −43,333 213,333
2018-05-01 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion +30,000 $10.69 $321K 129,739
2018-05-01 Labrucherie Gil M SVP & Chief Financial Officer Sale −30,000 $83.65 $2.5M 99,739
2018-05-01 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion · Stock Option −30,000 60,000
2018-05-01 ROBIN HOWARD W President & CEO Exercise or conversion +43,334 $10.69 $463K 280,481
2018-05-01 ROBIN HOWARD W President & CEO Sale −43,334 $83.65 $3.6M 237,147
2018-05-01 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −43,334 256,666
2018-04-17 WHITFIELD ROY A Director Exercise or conversion +30,000 $14.26 $428K 172,000
2018-04-17 WHITFIELD ROY A Director Exercise or conversion · Stock Option −30,000 0
2018-04-16 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +13,881 $10.69 $148K 82,738
2018-04-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −13,881 $101.46 $1.4M 68,857
2018-04-16 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −13,881 16,119
2018-04-10 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +502 $7.21 $4K 80,763
2018-04-10 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −502 $105.67 $53K 80,261
2018-04-10 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion · Stock Option −502 32,500

Page 33 of 43 · 847 trades